Molecular genetic medicine
著者
書誌事項
Molecular genetic medicine
Academic Press, c1991-c1994
- v. 1
- v. 2
- v. 3
- v. 4
大学図書館所蔵 件 / 全8件
-
v. 1491.69||Fr||110231665,
v. 2491.69||Fr||210231674, v. 3491.69||Fr||310231683, v. 4491.69||Fr||410231692 -
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographies and index
内容説明・目次
- 巻冊次
-
v. 2 ISBN 9780124620025
内容説明
Molecular Genetic Medicine, Volume II, summarizes progress in several of the most important areas of modern molecular genetics and medicine. The chapters deal with ancient and common genetic diseases, a new infectious disease that threatens to become a world-wide scourge for all of humanity, and two of the most important and still poorly understood causes of mental retardation. The common thread winding through these separate stories is the astounding illumination of all these disorders by modern molecular genetic studies. The book opens with a chapter on the history of the molecular approach to the thalassemias, among the most common and severe of all human genetic diseases. Separate chapters follow covering the history and current state of the fragile X syndrome; the mechanisms of hepatitis B viral gene expression, its relation to liver cancer, and its prevention; and molecular genetics of Down syndrome. Subsequent chapters deal with mammalian X chromosome inactivation; the use of the human hprt locus as a model system for analyzing mutation in human cells in vivo; and the regulatory genes and factors that govern virus replication of HIV-1.
目次
Contributors
Preface
1 The Impact of Molecular Biology on the Diagnosis and Treatment of Hemoglobin Disorders
I. Diseases of Hemoglobin
II. Globin Gene Organization
III. Control of Globin Gene Expression
IV. Thalassemias
V. Hemoglobinopathies
VI. Analysis of Globin Gene Function
VII. Switching
VIII. Gene Therapy
References
2 The fragile X Syndrome
I. Introduction
II. History of the fragile X Syndrome
III. Epidemiology of fragile X Syndrome
IV. Features of Affected and Transmitting Males
V. The Association of fragile X and Autism
VI. Carrier Females
VII. Cytogenetics of the fragile X Syndrome
VIII. Treatment
IX. Prenatal Diagnosis
X. DNA Molecular Markers
XI. Theories Regarding the Nature of the fra(X) Mutation
XII. Approaches to Define the Nature of the Mutation
XIII. Conclusions
References
3 Hepatitis B Virus Biology and Pathogenesis
I. Overview of the Problem
II. Discovery of the Virus
III. Genetic Organization of the HBV Genome
IV. Viral Morphogenesis
V. Hepatocellular Carcinoma
VI. Future Prospects, Opportunities, and Challenges
References
4 The Molecular Genetics of Down Syndrome
I. Introduction
II. Gene Dosage Effects
III. Molecular Definition of the DS Region of HSA-21
IV. Animal Models of Down Syndrome
V. Summary
References
5 Mammalian X Chromosome Inactivation
I. Introduction
II. Initiation of X Inactivation
III. Spreading of the X Inactivation Signal
IV. Maintenance of X Inactivation
V. Perspectives
References
6 Molecular Analysis off Mutation in the Human Gene for Hypoxanthine Phosphoribosyltransferase
I. Introduction
II. The HPRT Enzyme and Clinical Features of HPRT Deficiency
III. Localization, Structure, and Expression of the hprt Gene
IV. Germ-Line Mutations in HPRT-Deficient Patients
V. Somatic hprt Mutations
VI. Considerations about the Somatic and Germ-Line Mutational Spectra in the Human hprt Gene
References
7 Regulatory Genes of Human Immunodeficiency Viruses
I. Introduction
II. Retrovirus Life Cycle
III. Coupling of Virus Replication to Cell Cycle and Activation
IV. HIV Regulatory Genes
V. The Tat Trans-Activation Pathway
VI. Expanded Repertoire of Tat Activities
VII. The Rev Trans-Activation Pathway
VIII. Viral Proteins
IX. Conclusions
References
Index
- 巻冊次
-
v. 3 ISBN 9780124620032
内容説明
This work opens with a chronicle of the birth and subsequent progress of gene therapy. It then reviews the recent research on cystic fibrosis, and covers the complex studies on Huntington's disease. It also explains the genetic interactions in astrocytic tumour progression and provides up-to-date information on the molecular biology of Alzheimer's disease.
目次
T. Friedmann, Milestones and Events in the Early Development of Human Gene Therapy.M.L. Drumm and R Collins, Molecular Biology of Cystic Fibrosis. JE Gusella, Hunting for Huntington's Disease. T. Mikkelsen, Genetics of Astrocytic Tumor Progression. Pi Whitehouse, G. Landreth, and S Younkin, Molecular Biology of Alzheimer's Disease.
- 巻冊次
-
v. 4 ISBN 9780124620049
内容説明
Continuing to keep pace with progress in human molecular genetics, Volume 4 of Molecular Genetic Medicine reviews five new areas of critical importance. Chapter 1 reviews the molecular mechanisms that have beenunraveled in the pathogenesis of eye diseases. The second chapter explains the remarkable new principle if genomic imprinting, or epigenetic modification imposed by parental history. Chapter 3 describes the etiology of amyotrophic lateral sclerosis, or Lou Gehrig's Disease, as effected by superdioxide dismutase function and neuron degeneration. The fourth chapter covers the normal and aberrant functions of peroxisomes, now implicated in many diseases, most notably adrenoleukodystrophy, publicized widelyby the"cure"called Lorenzo's oil. The final chapter summarizes recombination techniques that permit functional new genetic material to be introduced into, and subsequently transmitted through, the germ line of mammalian cells. These amazing methods arehaving profound impacts on medicine and on concepts of the study of normal human development and disease.
目次
G.C.M. Black and I.W. Craig, The Molecular Genetics of Blindness. D.J. Driscoll, Genomic Imprinting in Humans. D. Patterson, H.R. Warner, L.M. Fox, and Z. Rahmani, Superoxide Dismutase, Oxygen Radical Metabolism, and Amyotrophic Lateral Sclerosis. E.A.C. Wiemer and S. Subramani, Protein Import Deficiencies in Human Peroxisomal Disorders. K.R. Thomas, The Impact of Gene Targeting on Medicine. Subject Index.
「Nielsen BookData」 より